A M Stafford1, C Reed1, T J Phillips2,3. 1. Department of Behavioral Neuroscience and Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, OR, USA. 2. Department of Behavioral Neuroscience and Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, OR, USA. phillipt@ohsu.edu. 3. Veterans Affairs Portland Health Care System, Portland, OR, USA. phillipt@ohsu.edu.
Abstract
RATIONALE: Genetic and non-genetic factors influence substance use disorders. Our previous work in genetic mouse models focused on genetic factors that influence methamphetamine (MA) intake. The current research examined several non-genetic factors for their potential influence on this trait. OBJECTIVES: We examined the impact on MA intake of several non-genetic factors, including MA access schedule, prior forced MA exposure, concomitant ethanol (EtOH) access, and gamma-aminobutyric acid type B (GABAB) receptor activation. Selectively bred MA high drinking (MAHDR) and low drinking (MALDR) mice participated in this research. RESULTS: MAHDR, but not MALDR, mice increased MA intake when given intermittent access, compared with continuous access, with a water choice under both schedules. MA intake was not altered by previous exposure to forced MA consumption. Male MAHDR mice given simultaneous access to MA, EtOH, and an EtOH+MA mixture exhibited a strong preference for MA over EtOH and EtOH+MA; MA intake was not affected by EtOH in female MAHDR mice. When independent MAHDR groups were given access to MA, EtOH, or EtOH+MA vs. water in each case, MA intake was reduced in the water vs. EtOH+MA group, compared with the water vs. MA group. The GABAB receptor agonist R(+)-baclofen (BAC) not only reduced MA intake but also reduced water intake and locomotor activity in MAHDR mice. There was a residual effect of BAC, such that MA intake was increased after termination of BAC treatment. CONCLUSIONS: These findings demonstrate that voluntary MA intake in MAHDR mice is influenced by non-genetic factors related to MA access schedule and co-morbid EtOH exposure.
RATIONALE: Genetic and non-genetic factors influence substance use disorders. Our previous work in genetic mouse models focused on genetic factors that influence methamphetamine (MA) intake. The current research examined several non-genetic factors for their potential influence on this trait. OBJECTIVES: We examined the impact on MA intake of several non-genetic factors, including MA access schedule, prior forced MA exposure, concomitant ethanol (EtOH) access, and gamma-aminobutyric acid type B (GABAB) receptor activation. Selectively bred MA high drinking (MAHDR) and low drinking (MALDR) mice participated in this research. RESULTS: MAHDR, but not MALDR, mice increased MA intake when given intermittent access, compared with continuous access, with a water choice under both schedules. MA intake was not altered by previous exposure to forced MA consumption. Male MAHDR mice given simultaneous access to MA, EtOH, and an EtOH+MA mixture exhibited a strong preference for MA over EtOH and EtOH+MA; MA intake was not affected by EtOH in female MAHDR mice. When independent MAHDR groups were given access to MA, EtOH, or EtOH+MA vs. water in each case, MA intake was reduced in the water vs. EtOH+MA group, compared with the water vs. MA group. The GABAB receptor agonist R(+)-baclofen (BAC) not only reduced MA intake but also reduced water intake and locomotor activity in MAHDR mice. There was a residual effect of BAC, such that MA intake was increased after termination of BAC treatment. CONCLUSIONS: These findings demonstrate that voluntary MA intake in MAHDR mice is influenced by non-genetic factors related to MA access schedule and co-morbid EtOH exposure.
Entities:
Keywords:
Addiction; Amphetamine; Ethanol; GABA; Self administration; Substance use disorder
Authors: Tara L Fidler; Matthew S Powers; Jason J Ramirez; Andrew Crane; Jennifer Mulgrew; Phoebe Smitasin; Christopher L Cunningham Journal: Addict Biol Date: 2011-09-28 Impact factor: 4.280
Authors: Spencer Bujarski; Daniel J O Roche; Katy Lunny; Nathasha R Moallem; Kelly E Courtney; Vincent Allen; Emily Hartwell; Adam Leventhal; Taylor Rohrbaugh; Lara A Ray Journal: Drug Alcohol Depend Date: 2014-06-17 Impact factor: 4.492
Authors: Alexandra M Stafford; Cheryl Reed; Harue Baba; Nicole Ar Walter; John Rk Mootz; Robert W Williams; Kim A Neve; Lev M Fedorov; Aaron J Janowsky; Tamara J Phillips Journal: Elife Date: 2019-07-09 Impact factor: 8.140
Authors: Michaelanne B Munoz; Claire L Padgett; Robert Rifkin; Miho Terunuma; Kevin Wickman; Candice Contet; Stephen J Moss; Paul A Slesinger Journal: J Neurosci Date: 2016-03-16 Impact factor: 6.167
Authors: Xiao Shi; Nicole A R Walter; John H Harkness; Kim A Neve; Robert W Williams; Lu Lu; John K Belknap; Amy J Eshleman; Tamara J Phillips; Aaron Janowsky Journal: PLoS One Date: 2016-03-31 Impact factor: 3.240
Authors: Gabriella Shab; Elissa K Fultz; Ariana Page; Michal A Coelho; Lindsey W Brewin; Nicholas Stailey; Chelsea N Brown; Camron D Bryant; Tod E Kippin; Karen K Szumlinski Journal: Behav Brain Res Date: 2020-10-11 Impact factor: 3.332
Authors: Tamara J Phillips; Tyler Roy; Sara J Aldrich; Harue Baba; Jason Erk; John R K Mootz; Cheryl Reed; Elissa J Chesler Journal: Front Psychiatry Date: 2021-08-26 Impact factor: 4.157